One line of evidence suggests that JNK activation promotes ECM degradation during AAA pathogenesis by increasing MMP production, specifically MMP9 from THP-1 monocyte–macrophages and Mmp2 from rodent VSMCs [78]. The gene discussed is MMP9; the disease is triple-A syndrome.